Author Archives: Tom Halkin
Every September, we join with friends across the cancer community in recognizing and honoring our most vulnerable cancer patients: kids. Childhood Cancer Awareness Month (CCAM) is a yearly reminder of the sacrifices and struggles that children and their families face after a cancer diagnosis, as well as the triumphs, achievements, and spirit of these brave […]
SEE THE JULY BRAIN TUMOR RESEARCH HIGHLIGHTS HERE. Over the years, NBTS has given more than $32 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship […]
Liquid Biopsies for Brain Tumors: Can We Improve Diagnosis, Treatment Decisions, and Research All Via One Advancement?
New research, supported by the Defeat GBM Research Collaborative, is paving the way for new advances in the diagnosis, monitoring, treatment planning, and research of brain tumors – both primary and metastatic. Dr. Ingo Mellinghoff – one of the Principle Investigators in the Defeat GBM Research Collaborative – and his colleagues at Memorial Sloan Kettering […]